The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug ...

They were randomized to flexible doses of Stalevo or levodopa/carbidopa IR administered four-times daily on a q3.5 h schedule with a target dose of approximately 400 mg levodopa per day.

Clinicians must remember that using two tablets of Stalevo at once not only increases the levodopa but doubles the entacapone dose to 400 mg so that it is recommended instead to use a single ...

Turmeric is typically taken in doses of 1.5 grams daily for up to three months ... such as Aldactone and CaroSpir (spironolactone) Zinc Sinemet (levodopa/carbidopa) Check with a healthcare provider or ...

This article will discuss the recommended hepatitis vaccine schedule for children and adults, including doses, timing, side effects, and who should get the vaccine. The following vaccines are approved ...

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

PHOTO/Shutterstock The European Commission, through its Health Emergency Preparedness and Response Authority (HERA), has delivered 10,000 doses of the MVABN® vaccine to Uganda to support the ...